Showing 2 of 2 recruiting trials for “secondary-interstitial-lung-disease-specific-to-childhood-associated-with-a-systemic-vasculitis”
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
👨⚕️ Zhang Huilan, PD, Tongji hospital affiliated to huazhong university of science and technology, Wuhan, hubei📍 1 site📅 Started Oct 2024View details ↗
ADSCs Therapy in Patients With CTD-ILD
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →